All Stories

  1. Creating and Testing New Drugs to Fight Breast Cancer by Blocking LPA1 Receptors
  2. Developing and Testing New Compounds to Fight Breast Cancer by Targeting LPA1 Receptors
  3. New Anti-HIV Drugs: Designing and Testing 1,3-Thiazolidine Pyrimidine Compounds
  4. Restoration of p53 functions by suppression of mortalin–p53 sequestration: an emerging target in cancer therapy
  5. Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole – 1,2,4‐Triazole Conjugates
  6. Evolution of Machine Learning in Tuberculosis Diagnosis: A Review of Deep Learning-Based Medical Applications
  7. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry
  8. Mass Spectrometry (MS/MS) and Proteomics
  9. Dengue structural proteins as antiviral drug targets: Current status in the drug discovery & development
  10. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development
  11. Antitubercular Potential of Novel Isoxazole Encompassed 1, 2, 4- Triazoles: Design, Synthesis, Molecular Docking Study and Evaluation of Antitubercular Activity
  12. Molecular Docking and Three‐Dimensional Quantitative Structure–Activity Relationships for Antitubercular Pyrimidine Derivatives
  13. Design, Synthesis and Antitubercular Evaluation of New Benzimidazole Scaffolds
  14. Design, synthesis, and cytotoxicity evaluation of new 2,4-disubstituted quinazolines as potential anticancer agents
  15. New benzothiazinone linked 1, 2, 4-triazoles: Design, synthesis, characterization, and evaluation of antitubercular activity
  16. Synthesis and in vitro Cytotoxicity Study of Novel 4-Substituted Quinazolines Encompassed with Thiazolidinone and Azetidinone
  17. Inclusion Complexes of Nateglinide with HP–β–CD and L-Arginine for Solubility and Dissolution Enhancement: Preparation, Characterization, and Molecular Docking Study
  18. Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis
  19. Synthesis of 1,3,4-oxadiazoles as promising anticoagulant agents
  20. Design, synthesis and evaluation of diphenyl ether analogues as antitubercular agents
  21. Synthesis and Evaluation of New 5-methylisoxazole-3-carboxamide Derivatives as Antitubercular Agents
  22. Structural insights of PA-824 derivatives: ligand-based 3D-QSAR study and design of novel PA824 derivatives as anti-tubercular agents
  23. Synthesis and crystal structure of 2-{5-[2-(2,6-dichlorophenylamino)benzyl]-4-p-tolyl-4H-1,2,4-triazol-3-ylthio}acetate
  24. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents
  25. Synthesis, in vitro cytotoxicity, and antibacterial studies of new asymmetric bis-1,2,4-triazoles
  26. Synthesis and Pharmacological Evaluation of 7-chloro-6-fluoro-2-(5-aminooxazol/thiazol-2-aryldenylamino)-benzo(1,3)thiazoles